These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 17349528

  • 1. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID.
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V.
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, Mayer D.
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [Abstract] [Full Text] [Related]

  • 5. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH.
    Prostate; 2010 Jun 01; 70(8):817-24. PubMed ID: 20054821
    [Abstract] [Full Text] [Related]

  • 6. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW.
    J Urol; 1995 Jul 01; 154(1):293-8. PubMed ID: 7539865
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 15. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.
    J Cell Biochem; 2006 Oct 01; 99(2):392-401. PubMed ID: 16639715
    [Abstract] [Full Text] [Related]

  • 16. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P, Marusic J, Stattin P, Bergh A.
    Prostate; 2009 Jun 01; 69(8):799-809. PubMed ID: 19189305
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2003 Feb 01; 54(2):79-87. PubMed ID: 12497580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Androgen receptor gene amplification and protein expression in recurrent prostate cancer.
    Ford OH, Gregory CW, Kim D, Smitherman AB, Mohler JL.
    J Urol; 2003 Nov 01; 170(5):1817-21. PubMed ID: 14532783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.